May 25, 2026
International Drug Safety Monitoring Systems Explained: How Global Networks Protect Patients
Explore the critical gaps in generic availability for combination Narrow Therapeutic Index (NTI) drugs. Learn why bioequivalence standards create barriers, how substitution risks affect patient safety, and what monitoring strategies are essential for complex regimens.
De facto combinations - taking separate generic pills instead of a single fixed-dose combination - offer dosing flexibility but increase the risk of missed doses and drug interactions. Learn when it’s safe and when it’s not.